The molecular basis of ocular HSV-1 infection has led to the identification of inhibitors of TANK-binding kinase 1 (TBK1) such as BX795, which strongly suppressed infection by multiple strains of HSV-1 in vivo [96]. This evidence concerns the gene TBK1 and infection.